RadNet (NASDAQ:RDNT) will be releasing its earnings data before the market opens on Tuesday, November 12th. Analysts expect RadNet to post earnings of $0.11 per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link.
RadNet (NASDAQ:RDNT) last issued its quarterly earnings results on Thursday, August 8th. The medical research company reported $0.10 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.02). RadNet had a return on equity of 18.91% and a net margin of 3.33%. The business had revenue of $289.10 million for the quarter, compared to analyst estimates of $272.36 million. During the same quarter last year, the firm earned $0.11 earnings per share. The firm’s quarterly revenue was up 18.3% compared to the same quarter last year. On average, analysts expect RadNet to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Shares of RDNT stock opened at $16.08 on Friday. The stock has a 50 day moving average of $14.93 and a 200-day moving average of $14.04. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 5.09. The firm has a market cap of $797.02 million, a PE ratio of 24.36, a price-to-earnings-growth ratio of 6.42 and a beta of 0.86. RadNet has a 12 month low of $9.97 and a 12 month high of $16.66.
Several analysts have recently commented on the company. BidaskClub cut RadNet from a “buy” rating to a “hold” rating in a report on Tuesday, October 29th. Zacks Investment Research upgraded RadNet from a “sell” rating to a “hold” rating in a report on Tuesday, October 8th. Three research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $17.75.
In related news, insider John V. Crues sold 50,000 shares of the firm’s stock in a transaction dated Monday, August 12th. The stock was sold at an average price of $15.07, for a total value of $753,500.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Michael L. Md Sherman sold 30,000 shares of the firm’s stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $15.19, for a total value of $455,700.00. Following the completion of the transaction, the director now owns 259,083 shares in the company, valued at approximately $3,935,470.77. The disclosure for this sale can be found here. In the last quarter, insiders sold 100,703 shares of company stock worth $1,522,850. 6.10% of the stock is owned by company insiders.
RadNet Company Profile
RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.
Read More: Why do companies engage in swaps?
Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.